On February 2, 2022, City of Hope announced that it has completed its previously announced acquisition of Cancer Treatment Centers of America (CTCA), a network of oncology hospitals and outpatient care centers across the United States. City of Hope, in Duarte, California, now has expanded its geographic footprint in cancer research and treatment, providing patients with cancer with timely access to quality care, clinical trials, and leading-edge innovation.
“With the completion of this acquisition, City of Hope and Cancer Treatment Centers of America are combining complementary strengths, with a shared commitment to providing the best, most compassionate care possible,” said Robert Stone, President and Chief Executive Officer (CEO) of City of Hope and the Helen and Morgan Chu CEO Distinguished Chair. “Together, we are creating a new model for how cancer care is delivered, leveraging real-world cancer care experience to inform scientific innovation and making tomorrow’s new discoveries available to the people who need them today.”
With CTCA, the combined organization will serve approximately 115,000 patients each year, with more than 11,000 team members and 575 physicians across a network of locations in California, Arizona, Illinois, and Georgia, expanding the portfolio, reach, and impact of City of Hope’s cancer services and research and development, to more patients, families, and communities nationwide.
City of Hope announced that it intends to begin the process of converting CTCA to a nonprofit organization.
